Bank of New York Mellon Corp - NEOGENOMICS INC ownership

NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 309 filers reported holding NEOGENOMICS INC in Q4 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of NEOGENOMICS INC
ValueSharesWeighting
Q3 2023$12,150,728
-26.6%
987,864
-4.2%
0.00%0.0%
Q2 2023$16,564,122
-10.3%
1,030,748
-2.9%
0.00%
-25.0%
Q1 2023$18,476,188
+85.5%
1,061,240
-1.5%
0.00%
+100.0%
Q4 2022$9,958,705
+4.8%
1,077,782
-2.3%
0.00%0.0%
Q3 2022$9,501,000
+10.7%
1,103,581
+4.8%
0.00%0.0%
Q2 2022$8,584,000
-40.4%
1,053,171
-11.1%
0.00%
-33.3%
Q1 2022$14,400,000
-69.6%
1,185,209
-14.7%
0.00%
-66.7%
Q4 2021$47,409,000
-30.7%
1,389,489
-2.0%
0.01%
-30.8%
Q3 2021$68,417,000
+8.9%
1,418,236
+2.0%
0.01%
+8.3%
Q2 2021$62,816,000
-7.5%
1,390,657
-1.2%
0.01%
-14.3%
Q1 2021$67,917,000
-10.5%
1,408,172
-0.1%
0.01%
-17.6%
Q4 2020$75,917,000
+46.2%
1,410,039
+0.2%
0.02%
+30.8%
Q3 2020$51,935,000
+18.1%
1,407,856
-0.9%
0.01%
+8.3%
Q2 2020$43,991,000
+9.1%
1,419,982
-2.8%
0.01%
-7.7%
Q1 2020$40,325,000
-9.9%
1,460,560
-4.6%
0.01%
+8.3%
Q4 2019$44,778,000
+57.2%
1,530,925
+2.8%
0.01%
+50.0%
Q3 2019$28,483,000
-15.6%
1,489,724
-3.1%
0.01%
-11.1%
Q2 2019$33,733,000
-9.9%
1,537,485
-16.0%
0.01%
-10.0%
Q1 2019$37,446,000
+279.4%
1,830,240
+133.8%
0.01%
+233.3%
Q4 2018$9,870,000
-27.1%
782,790
-11.3%
0.00%0.0%
Q3 2018$13,543,000
+47.6%
882,244
+26.0%
0.00%
+50.0%
Q2 2018$9,177,000
+59.9%
700,072
-0.5%
0.00%0.0%
Q1 2018$5,740,000
-20.8%
703,512
-14.0%
0.00%0.0%
Q4 2017$7,249,000
-33.7%
818,196
-16.7%
0.00%
-33.3%
Q3 2017$10,935,000
+29.3%
982,560
+4.1%
0.00%
+50.0%
Q2 2017$8,456,000
+36.9%
943,784
+20.5%
0.00%0.0%
Q1 2017$6,178,000
-16.3%
783,011
-9.1%
0.00%0.0%
Q4 2016$7,385,000
+0.1%
861,720
-4.0%
0.00%0.0%
Q3 2016$7,380,000
+13.3%
897,824
+10.8%
0.00%0.0%
Q2 2016$6,514,000
+158.1%
810,167
+116.4%
0.00%
+100.0%
Q1 2016$2,524,000
-0.9%
374,361
+15.7%
0.00%0.0%
Q4 2015$2,547,000
+175.4%
323,630
+100.6%
0.00%
Q3 2015$925,000
-29.5%
161,300
-33.5%
0.00%
Q2 2015$1,312,000
+216.1%
242,605
+173.1%
0.00%
Q1 2015$415,000
+3.8%
88,844
-7.4%
0.00%
Q4 2014$400,000
-30.4%
95,916
-13.1%
0.00%
Q3 2014$575,000
+159.0%
110,327
+64.3%
0.00%
Q2 2014$222,000
-50.3%
67,148
-47.9%
0.00%
Q1 2014$447,000
-5.3%
128,846
-1.1%
0.00%
Q4 2013$472,000
-20.5%
130,293
-34.1%
0.00%
Q3 2013$594,000
+50.8%
197,730
+99.3%
0.00%
Q2 2013$394,00099,1910.00%
Other shareholders
NEOGENOMICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Kopp Family Office, LLC 1,516,313$14,0118.43%
Greenhouse Funds LLLP 2,795,231$25,827,9342.36%
First Light Asset Management, LLC 2,682,171$24,783,2602.30%
PERKINS CAPITAL MANAGEMENT INC 197,700$1,8271.93%
Altium Capital Management LP 285,000$2,633,4001.34%
EMERALD MUTUAL FUND ADVISERS TRUST 1,654,543$15,287,9770.95%
EMERALD ADVISERS, LLC 2,101,567$19,418,4790.94%
Bullseye Asset Management LLC 105,997$9800.53%
OAK FAMILY ADVISORS, LLC 101,194$935,0330.50%
FORMULA GROWTH LTD 180,300$1,665,9720.47%
View complete list of NEOGENOMICS INC shareholders